Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Royer

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2001
Inhibition of IgE-induced activation of human mast cells by IL-10B Royer, S Varadaradjalou, P Saas, et al.
Oncogene|April 6, 1995
The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL)B Royer-Pokora, M Rogers, T H Zhu, et al.
Radiation Protection Dosimetry|December 15, 2022
ASSESSMENT OF OVERRANGING AS A FUNCTION OF PITCH, COLLIMATION AND ROTATION TIME FOR THREE OF THE MOST RECENT AND WIDESPREAD CT SCANS IN FRANCEL A González-Méndez, J Bozec, I Rousselle, et al.
Diabetologia|March 5, 2005
Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402B Balkau, T Hillier, E Vierron, et al.
Virology|November 1, 1977
In vitro transformation with avian myelocytomatosis virus strain CMII: characterization of the virus and its target cellsT Graf, B Royer-Pokora, W Meyer-Glauner, et al.
European Journal of Biochemistry|August 1, 1997
Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potentialA Poleev, O Okladnova, A M Musti, et al.
ESMO Open|June 2, 2023
Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotypingB Royer, M Launay, J Ciccolini, et al.
Pharmacology|June 24, 2009
Tyrosine kinase inhibitors and solid tumours: case report and review of the literatureF Roszkiewicz, R Garidi, I Vaida, et al.
Journal of Medical Genetics|May 3, 2005
STK11 genotyping and cancer risk in Peutz-Jeghers syndromeV Schumacher, T Vogel, B Leube, et al.
Leukemia|February 3, 2007
The tyrosine-kinase inhibitor imatinib induces long-term remission in a patient with chronic myelogenous leukemia with translocation t(4;22)F Neumann, A Poelitz, B Hildebrandt, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2001
Inhibition of IgE-induced activation of human mast cells by IL-10B Royer, S Varadaradjalou, P Saas, et al.
Oncogene|April 6, 1995
The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL)B Royer-Pokora, M Rogers, T H Zhu, et al.
Radiation Protection Dosimetry|December 15, 2022
ASSESSMENT OF OVERRANGING AS A FUNCTION OF PITCH, COLLIMATION AND ROTATION TIME FOR THREE OF THE MOST RECENT AND WIDESPREAD CT SCANS IN FRANCEL A González-Méndez, J Bozec, I Rousselle, et al.
Diabetologia|March 5, 2005
Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402B Balkau, T Hillier, E Vierron, et al.
Virology|November 1, 1977
In vitro transformation with avian myelocytomatosis virus strain CMII: characterization of the virus and its target cellsT Graf, B Royer-Pokora, W Meyer-Glauner, et al.
European Journal of Biochemistry|August 1, 1997
Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potentialA Poleev, O Okladnova, A M Musti, et al.
ESMO Open|June 2, 2023
Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotypingB Royer, M Launay, J Ciccolini, et al.
Pharmacology|June 24, 2009
Tyrosine kinase inhibitors and solid tumours: case report and review of the literatureF Roszkiewicz, R Garidi, I Vaida, et al.
Journal of Medical Genetics|May 3, 2005
STK11 genotyping and cancer risk in Peutz-Jeghers syndromeV Schumacher, T Vogel, B Leube, et al.
Leukemia|February 3, 2007
The tyrosine-kinase inhibitor imatinib induces long-term remission in a patient with chronic myelogenous leukemia with translocation t(4;22)F Neumann, A Poelitz, B Hildebrandt, et al.
Pageof 14